
|Articles|July 1, 2002
Study finds wide variation in branded supplements
Orlando, FL-A study from the University of Toronto has created a credo for urology patients who purchase products from the $27 billion nutritional supplement industry: "Caveat emptor"-let the buyer beware.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
4
FDA approves first-line Zenflow system for the treatment of BPH
5















